Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

In total, 5% of dogs and 13% of cats tested positive for COVID-19 on polymerase chain reaction, and 25% and 36%, respectively ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Infection with the SARS-CoV-2 Omicron variant confers weak, short-term protection against reinfection, compared with the much ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...

Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women.

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.